by Maria Zannes | Jun 10, 2020 | Press Releases
Trial results of automated test demonstrate non-invasive CyPath® Lung is highly accurate in finding lung cancer FAQ: Answers to Questions about Cypath® Lung JUNE 10, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced its...
by Maria Zannes | Jan 8, 2020 | Events
State of the Industry is February 11th, 2020 at the Grand Hyatt in San Antonio, TX. The premier annual event celebrating the people of San Antonio’s healthcare and bioscience industry conveys five stories in the effort to advance human health. Maria Zannes will...
by Maria Zannes | Oct 31, 2019 | Events
7th Annual UTSA Innovation Awards Tuesday, November 12, 2019 6 p.m. Reception | 7 p.m. Dinner Eilan Hotel — Incanto Ballroom 18603 La Cantera Terrace San Antonio, TX 78256 Keynote: Maria Zannes, CEO of BioAffinity Techonlogies Inc. The annual UTSA Innovation Awards...
by Maria Zannes | Oct 11, 2019 | Events, Press Releases
OCTOBER 11, 2019 (San Antonio, TX) bioAffinity Technologies, a privately-held biotech company, today announced that it has been accepted as a member of the American Cancer Society’s National Lung Cancer Roundtable (NLCRT), a collaborative whose membership is focused...
by Maria Zannes | Oct 2, 2019 | Press Releases
OCTOBER 2, 2019 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced the members of its Scientific and Medical Advisory (SMA) Board who will provide independent expert advice and counsel on the Company’s research and...
